High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma.
about
Tumour Cell HeterogeneityThe influence of subclonal resistance mutations on targeted cancer therapyOral cavity and oropharyngeal squamous cell carcinoma--an updateEvolutionary determinants of cancerThe role of surgeons in building a personalized medicine programMolecular Aspects of Head and Neck Cancer TherapyCan oncology recapitulate paleontology? Lessons from species extinctionsIntra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome AtlasThe challenges of tumor genetic diversity.Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNAMulti-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss.Are all cancer stem cells created equal?Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer.Ultradeep analysis of tumor heterogeneity in regions of somatic hypermutationSingle-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.A novel approach for next-generation sequencing of circulating tumor cellsIntra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection.Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastasesEXPANDS: expanding ploidy and allele frequency on nested subpopulations.Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma.The non-coding landscape of head and neck squamous cell carcinomaInference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent copy number variation in IPO11 and prognostic significance of importin-11 overexpression on poor survival.Control of cancer formation by intrinsic genetic noise and microenvironmental cues.Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.Single circulating tumor cell sequencing as an advanced tool in cancer management.Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer.Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors.Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.Tumor evolution: Linear, branching, neutral or punctuated?Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma.Single-cell mutational profiling and clonal phylogeny in cancer.A population genetics perspective on the determinants of intra-tumor heterogeneity.
P2860
Q26765895-79ECE363-A13B-4B1D-B769-A58888856C70Q26781693-35979691-479B-448C-86A1-CFA3E18B32C8Q26799210-7A6C65F8-1F96-4139-A121-341210A4E87DQ26801710-789024D7-6112-4DF1-A705-78D6B0561E33Q26849667-F9301CE6-C4B6-405D-84DA-9070836F26DCQ28082815-F74148E0-4833-423A-B16B-4D836EA00941Q28607703-296A6976-18BC-4DEE-A43B-80F2B29BBD5FQ28650140-45057B07-E7D2-4D1C-ABEE-32D4063765CDQ30241056-84AF159F-C403-4B25-BD61-7EDC5614A89FQ31043365-DF6060C9-2DDD-4735-B667-F997457A7A7FQ33737740-E0F20C10-4B03-4216-91DF-242D1EAC6990Q34098286-1BE5B5DC-51DB-4033-94CC-D1DE5B0A2764Q34273110-EA8D8B82-6854-4B7B-8E28-E95398F5E15DQ34339885-FA0A2041-9A02-4559-998E-E8DF1A3E9D76Q35401680-EAF220D3-8235-425F-9D2B-F1EA8238ECFBQ35863199-54F362DF-2C60-4E5C-90C2-F7CA0265B3A7Q36088952-56E12747-274A-47E4-A2DA-316658A37AA5Q36089548-6D3FB60F-4DED-4841-B7F2-624DDA6C6CAAQ36544134-C4FDF199-9CB7-492E-BD32-C7E7F5B69EBEQ36547246-78AE6C47-2B5F-48FF-A789-E6743703F373Q36962873-6EED7A17-F4EF-4D23-AF15-505701FD94A8Q37317206-0EEFFF4D-86A6-42F7-961B-D81F3B130F7EQ37352557-EC52EC11-5205-46EE-8F6D-BAB58E8B3A9CQ37400092-3AD4B9DA-DD83-4455-9874-C254E6312DFAQ37536791-61EEB47C-299D-4C9E-939D-F7E36E7B35F3Q37588267-1E6D0241-9F66-4A78-83D7-630B3538563BQ37592617-9F9DAB66-0338-4BD7-B971-FF1C3A90B52DQ37688998-A60BC187-E872-4201-9C3A-7EBBBB49DAFCQ38544198-1B143A7C-EE13-4CA3-B142-5FA3CBC88CB3Q38602856-6444BB5A-7692-4458-8152-5F56B23413A2Q38631119-01295BEB-16AA-4391-B811-986C44E66E42Q38680776-1AD89AAC-5DB7-4E18-9D9A-B8FF54599259Q38808490-7729D788-2429-47A7-8641-92A56795F8C5Q38947597-026D9FCF-5743-4C8E-A204-DBEBF715E5C8Q39000737-AE202DE7-38A0-4E46-8CFD-E1F2E83A69CEQ39007635-FB2E0872-918A-45E8-BDE0-450A2F6DA440Q39017596-019FB750-A31B-42F8-B5B5-01908A86ADEFQ39025867-65F17C97-0B35-4ED6-9BD0-74BE5E070DA2Q39093250-E539972F-C731-42F6-A2F8-95FA7E2DDAE7Q39169154-36C8FFDF-0A30-45F0-B531-039CDD3B6047
P2860
High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High intratumor genetic hetero ...... neck squamous cell carcinoma.
@en
High intratumor genetic hetero ...... neck squamous cell carcinoma.
@nl
type
label
High intratumor genetic hetero ...... neck squamous cell carcinoma.
@en
High intratumor genetic hetero ...... neck squamous cell carcinoma.
@nl
prefLabel
High intratumor genetic hetero ...... neck squamous cell carcinoma.
@en
High intratumor genetic hetero ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
High intratumor genetic hetero ...... d neck squamous cell carcinoma
@en
P2093
Aaron D Tward
Edmund A Mroz
James W Rocco
Jeffrey N Myers
P2860
P304
P356
10.1002/CNCR.28150
P407
P577
2013-05-20T00:00:00Z